In accordance with this invention a novel pharmaceutical product containing efavirenz, emtricitabine and tenofovir DF are provided as a multicomponent unitary oral dosage form, component 1 comprising tenofovir DF (and, optionally, emtricitabine) and component 2 comprising efavirenz, wherein components 1 and 2 are in...
Documents
Form INC-22-04042021_signed
Form AOC-4(XBRL)-03042021_signed
Copies of the utility bills as mentioned above (not older than two months)-29122020
Approval letter of extension of financial year of AGM-30122020
Proof of Registered Office address(Conveyance/Lease deed/Rent Agreement along with the rent receipts) etc-29122020
Optional Attachment-(1)-29122020
Copy of board resolution authorizing giving of notice-29122020
XBRL financial statements duly authenticated as per section 134 (including Board's report,auditor's report and other documents)-30122020
Form MGT-14-19122020_signed
Optional Attachment-(2)-18122020
Copy(s) of resolution(s) along with copy of explanatory statement under section 173-18122020
Optional Attachment-(1)-18122020
Form MSME FORM I-06042020_signed
Copy of MGT-8-23122019
List of share holders, debenture holders;-23122019
Form MGT-7-23122019_signed
Form AOC-4(XBRL)-29112019_signed
XBRL financial statements duly authenticated as per section 134 (including Board's report,auditor's report and other documents)-28112019
Form DIR-12-26102019_signed
Optional Attachment-(1)-26102019
Optional Attachment-(2)-26102019
Optional Attachment-(2)-06092019
Form DIR-12-06092019_signed
Optional Attachment-(1)-06092019
Declaration of the appointee director, Managing director, in Form No. DIR-2;-06092019